PharVision Advisers’s US Bancorp USB Stock Holding History

PharVision Advisers’s Portfolio USB Stock Details USB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,083	Closed	-$215K	–	437
2025 Q1	$215K	Buy	+5,083	New	+$235K	0.3%	183

Other funds holding USB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

PharVision Advisers's USB Position: Q2 2025 in Review

PharVision Advisers sold out of US Bancorp (USB) in Q2 2025, closing a stake of 5,083 shares — an estimated $215K sold.

PharVision Advisers first reported a position in USB in Q1 2025 and held it in 1 quarter. The position peaked at $215K in Q1 2025. 1,836 funds tracked by Wall St. Rank hold USB as of Q2 2025.

PharVision Advisers reported no remaining US Bancorp position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 5,083 US Bancorp shares in Q2 2025, an estimated $215K.
PharVision Advisers first reported a position in US Bancorp in Q1 2025 and held it in 1 quarter.
PharVision Advisers's US Bancorp position peaked at $215K in Q1 2025.
1,836 funds tracked by Wall St. Rank held US Bancorp as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.